JPRN-UMIN000021074
Recruiting
未知
The changes in visual function after intravitreal bevacizmab for ocular neovascular diseases - The changes in visual function after intravitreal bevacizmab for ocular neovascular diseases
Ophthalmology, Kagoshima university0 sites50 target enrollmentFebruary 17, 2016
ConditionsOcular neovascular diseases
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Ocular neovascular diseases
- Sponsor
- Ophthalmology, Kagoshima university
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Ocular non\-neovascular diseases
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Macular structure and function after intravitreal injection of bevacizumab for wet macular degeneration a interventional study. - NDEUCTR2005-006014-18-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI20
Active, not recruiting
Not Applicable
Macular structure and function after intravitreal injection of bevacizumab for vascular retinopathy a interventional study. - NDvascular retinopathyMedDRA version: 6.1Level: PTClassification code 10038923EUCTR2006-001678-25-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI20
Active, not recruiting
Phase 1
Modification of the visual outcome after optic neuritis in CIS or MS by Gilenya®EUCTR2011-004787-30-DECharite Universitaetsmedizin Berlin88
Completed
Not Applicable
Patient with diabetic retinopathy undergoing intravitreal Avastin injection.CTRI/2018/04/012956Giridhar Eye Institute20
Recruiting
Phase 2
Comparative study of the effect of intravitreal injection of bevacizumab versus simultaneous intravitreal injection of bevacizumab and triamcinolone acetonideRetinal vascular occlusions.Retinal vascular occlusionsIRCT20130812014333N185Kermanshah University of Medical Sciences58